ストックスクリーナーアプリを入手
80.58
1.79%
1.68
前日終値:
$78.90
開ける：
$79.62
24時間の取引高:
256.77K
Relative Volume:
0.42
時価総額：
$2.33B
収益：
$267.23M
当期純損益:
$-83.50M
株価収益率:
-25.91
EPS:
-3.11
ネットキャッシュフロー:
$-59.99M
1週間 パフォーマンス:
-11.43%
1か月 パフォーマンス:
-23.43%
6か月 パフォーマンス:
-36.39%
1年 パフォーマンス:
-18.98%
1日の値動き範囲:
$79.09
$82.83
1週間の範囲:
$78.39
$90.88
52週間の値動き範囲:
$55.17
$170.87
Genedx Holdings Corp Stock (WGS) Company Profile
Compare WGS vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
80.51 | 2.28B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
514.84 | 192.99B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
208.62 | 148.11B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
653.46 | 52.49B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
116.68 | 35.28B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
316.62 | 31.33B | 3.17B | 642.63M | 516.49M | 10.77 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-09 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2025-10-20 | 開始されました | Canaccord Genuity | Buy |
| 2025-07-09 | 開始されました | Piper Sandler | Overweight |
| 2025-05-15 | 開始されました | Guggenheim | Buy |
| 2025-05-09 | アップグレード | Jefferies | Hold → Buy |
| 2024-08-28 | 開始されました | Wells Fargo | Equal Weight |
| 2024-07-10 | 開始されました | Craig Hallum | Buy |
| 2024-06-03 | 再開されました | Jefferies | Hold |
すべてを表示
Genedx Holdings Corp (WGS) 最新ニュース
HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - Finviz
Why GeneDx Holdings (WGS) Is Down 11.3% After Reaffirming 2026 Guidance And Narrowing 2025 Losses - simplywall.st
GeneDx to Participate in Upcoming Investor Conferences - Yahoo Finance
How The GeneDx Holdings (WGS) Narrative Is Shifting With GenomeDx Prenatal And Valuation Expectations - Yahoo Finance
Aug PreEarnings: What is the long term forecast for GeneDx Holdings Corp Equity Warrant stock2025 Growth vs Value & Weekly Momentum Picks - baoquankhu1.vn
These Analysts Slash Their Forecasts On GeneDx After Q4 Results - Benzinga
GeneDx stock slips premarket as analysts trim targets after 2025 results and 2026 outlook - Bez Kabli
GeneDx Holdings Corp. (WGS) Surged Following Strong Earnings and Improved Guidance - Insider Monkey
GeneDx: The Growth Story Isn't Dead, It's Changing (Rating Upgrade) (NASDAQ:WGS) - Seeking Alpha
BTIG cuts GeneDx stock price target on back-end loaded growth outlook By Investing.com - Investing.com Australia
BTIG cuts GeneDx stock price target on back-end loaded growth outlook - Investing.com Australia
GeneDx price target lowered to $150 from $180 at Jefferies - TipRanks
GeneDx Q4 2025 slides: 54% revenue growth, aggressive 2026 expansion - Investing.com India
Canaccord Genuity reiterates Buy on GeneDx stock, keeps $170 target - Investing.com Nigeria
Genedx Holdings Warned of Potential Goodwill and Intangible Asset Impairments That Could Hit Earnings - TipRanks
GeneDx Q4 2025 slides: 54% revenue growth, aggressive 2026 expansion By Investing.com - Investing.com Australia
GeneDx (WGS) Q4 2025 Earnings Call Transcript - AOL.com
Wells Fargo Upgrades GeneDx Amidst Market Excitement - StocksToTrade
GeneDx rises on Q4 beats, reiterating 2026 revenue guidance - MSN
GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026 - BioSpace
GeneDx Holdings Corp. Q4 2025 Earnings Call Summary - Yahoo Finance
GeneDx Q4 Earnings Call Highlights - Yahoo Finance
GeneDx Holdings Corp. (WGS) Q4 Earnings and Revenues Beat Estimates - Bitget
GeneDx stock maintained at Buy by TD Cowen ahead of results call - Investing.com India
GeneDx Holdings Corp (NASDAQ:WGS) Reports Mixed Q4 2025 Results, Stock Falls Despite Strong 2026 Outlook - ChartMill
GENEDX ($WGS) Releases Q4 2025 Earnings - Quiver Quantitative
GeneDx posts mixed Q4 performance as earnings miss but revenue tops estimates - MSN
GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results - TradingView
INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026 - The AI Journal
GeneDx reports Q4 adjusted EPS 14c, consensus 12c - TipRanks
GeneDx Slides To Net Loss In Q4; Reaffirms FY26; Shares Up In Pre-market - Nasdaq
GeneDx delivers mixed Q4 results By Investing.com - Investing.com UK
(WGS) GeneDx Expects 2026 Revenue Range $540M to $555M, vs. FactSet Est of $538.8M - marketscreener.com
Earnings Flash (WGS) GeneDx Holdings Corp. Posts Q4 Adjusted EPS $0.14 per Share, vs. FactSet Est of $0.10 - marketscreener.com
GeneDx Holdings Q4 Earnings Report: What Investors Need to Know - Benzinga
Here are the major earnings before the open Monday - MSN
GeneDx (NASDAQ:WGS) Shares Down 8%Here's What Happened - MarketBeat
A Preview Of GeneDx Hldgs's Earnings - Benzinga
Investors brace for GeneDx earnings amid profitability questions By Investing.com - Investing.com Canada
Earnings To Watch: GeneDx Holdings Corp (WGS) Reports Q4 2025 Re - GuruFocus
Ideas Watch: Will GeneDx Holdings Corp. stock deliver shareholder valueJuly 2025 Setups & Daily Profit Focused Screening - mfd.ru
US Stocks Recap: What is the long term forecast for GeneDx Holdings Corp Equity Warrant stockIndex Update & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Breakout Watch: Will Zura Bio Limited benefit from rising consumer demand2025 Winners & Losers & Safe Entry Point Identification - baoquankhu1.vn
GeneDx Holdings Corp. (WGS) Stock Analysis: Exploring An 88.57% Upside Potential - DirectorsTalk Interviews
Is GeneDx Holdings Corp. Equity Warrant stock showing strong momentumTrade Risk Report & Short-Term High Return Strategies - mfd.ru
Evaluating GeneDx Holdings (WGS) Valuation After Recent Share Price Weakness - Yahoo Finance
Genedx Holdings Corp (WGS) 財務データ
収益
当期純利益
現金流量
EPS
Genedx Holdings Corp (WGS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Dechairo Bryan | Chief Operating Officer |
Feb 01 '26 |
Option Exercise |
0.00 |
9,374 |
0 |
9,374 |
| Dechairo Bryan | Chief Operating Officer |
Feb 02 '26 |
Sale |
99.53 |
3,413 |
339,682 |
5,961 |
0.98%
0.98%
大文字化:
|
ボリューム (24 時間):